Corpus ID: 207868535

LINICAL ADVANCES IN LIVER , PANCREAS , ND BILIARY TRACT ncreased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty iver Disease

@inproceedings{DUSHAYLINICALAI,
  title={LINICAL ADVANCES IN LIVER , PANCREAS , ND BILIARY TRACT ncreased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty iver Disease},
  author={ODY DUSHAY and Patricia C. Chui and Gosala S. Gopalakrishnan and Marta Rey and Meghan Crawley and F M Fisher and Michael K. Badman and M. L. Martinez Chantar and Eleftheria Maratos Flier}
}
fi K l p ACKGROUND & AIMS: Fibroblast growth factor 21 FGF21) is an hepatic protein that plays a critical role in etabolism, stimulating fatty acid oxidation in liver and lucose uptake in fat. Systemic administration to obese odents and diabetic monkeys leads to improved glucose omeostasis and weight loss. In rodents, FGF21 increases ith fasting and consumption of a ketogenic diet (KD). n humans, FGF21 correlates with body mass index BMI), but studies evaluating other parameters show… CONTINUE READING

Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

Figures from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Circulating FGF 21 is induced by PPAR agonists but not ketosis in man

  • M Mraz, M Bartlova, Z Lacinova
  • J Clin Endocrin Metab
  • 2009

Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity

  • E Berglund, Y Candice, H Bina
  • Endocrinology
  • 2009